BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 18701947)

  • 21. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment options for primary sclerosing cholangitis.
    Sinakos E; Lindor K
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):473-88. PubMed ID: 20678020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
    Ahn DW
    Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent primary sclerosing cholangitis: Clinical diagnosis and long-term management issues.
    Gordon F
    Liver Transpl; 2006 Nov; 12(11 Suppl 2):S73-5. PubMed ID: 17051565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
    Leftwich H; Fang YM; Borgida A; Crombleholme W
    J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary sclerosing cholangitis: updates in diagnosis and therapy.
    Portincasa P; Vacca M; Moschetta A; Petruzzelli M; Palasciano G; van Erpecum KJ; van Berge-Henegouwen GP
    World J Gastroenterol; 2005 Jan; 11(1):7-16. PubMed ID: 15609388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACG Clinical Guideline: Primary Sclerosing Cholangitis.
    Lindor KD; Kowdley KV; Harrison ME;
    Am J Gastroenterol; 2015 May; 110(5):646-59; quiz 660. PubMed ID: 25869391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
    Voigtländer T; Wlecke J; Negm AA; Lenzen H; Manns MP; Lankisch TO
    J Clin Gastroenterol; 2014; 48(10):866-9. PubMed ID: 24440929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary sclerosing cholangitis in children versus adults: lessons for the clinic.
    Adike A; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1025-1032. PubMed ID: 30199272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant.
    Heneghan MA; Tuttle-Newhall JE; Suhocki PV; Muir AJ; Morse M; Bornstein JD; Sylvestre PB; Collins B; Kuo PC; Rockey DC
    Am J Transplant; 2003 May; 3(5):634-8. PubMed ID: 12752322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of primary sclerosing cholangitis: conventions and controversies.
    Chandok N; Hirschfield GM
    Can J Gastroenterol; 2012 May; 26(5):261-8. PubMed ID: 22590699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary sclerosing cholangitis: diagnosis, prognosis, and management.
    Singh S; Talwalkar JA
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):898-907. PubMed ID: 23454027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
    Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary sclerosing cholangitis.
    Karlsen TH; Schrumpf E; Boberg KM
    Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):655-66. PubMed ID: 20955968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
    Smith T; Befeler AS
    Curr Gastroenterol Rep; 2007 Mar; 9(1):54-9. PubMed ID: 17335678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.